Bs. Cain et al., Tumor necrosis factor-alpha and interleukin-1 beta synergistically depresshuman myocardial function, CRIT CARE M, 27(7), 1999, pp. 1309-1318
Objective: Proinflammatory cytokines such as tumor necrosis factor (TNF)-al
pha and interleukin (II)-1 beta have been implicated in the pathogenesis of
myocardial dysfunction in ischemia-reperfusion injury, sepsis, chronic hea
rt failure, viral myocarditis, and cardiac allograft rejection. Although ci
rculating TNF-alpha and IL-1 beta are both often elevated in septic shock,
it remains unknown whether TNF-alpha or IL-1 beta are the factors induced d
uring sepsis that directly depress human myocardial function, and if so, wh
ether the combination synergistically depresses myocardial function. Furthe
rmore, the mechanism(s) by which these cytokines induce human myocardial de
pression remain unknown. We hypothesized the following: a) TNF-alpha and IL
-1 beta directly depress human myocardial function; b) together, TNF-alpha
and IL-1 beta act synergistically to depress human myocardial function; and
c) inhibition of ceramidase or nitric oxide synthase attenuates myocardial
depression induced by TNF-alpha or IL-1 beta by limiting proximal cytokine
signaling or production of myocardial nitric oxide (NO).
Design:Prospective, randomized, controlled study.
Setting: Experimental laboratory in a university hospital.
Subjects: Freshly obtained human myocardial trabeculae.
Interventions: Human atrial trabeculae were obtained at the time of cardiac
surgery, suspended in organ baths, and field simulated at 1 Hz, and the de
veloped force was recorded. After a 90-min equilibration, TNF-alpha (1.25,
12.5, 125, or 250 pg/mL for 20 mins), IL-1 beta (6.25, 12.5, 50, or 200 pg/
mL for 20 mins), or TNF-alpha (1.25 pg/mL) plus IL-1 beta (6.25 pg/mL) were
added to the bath, and function was measured for the subsequent 100 mins a
fter the 20-min exposure. To assess the roles of the sphingomyelin and NO p
athways in TNF-alpha and IL-1 beta cross-signaling, the ceramidase inhibito
r N-oleoyl ethanolamine (1 mu M) or the NO synthase inhibitor NG-monomethyl
-L-arginine (10 mu M) was added before TNF-alpha (125 pg/mL) or IL-beta (50
pg/mL).
Measurements and Main Results:TNF-alpha and IL-1 beta each depressed human
myocardial function in a dose-dependent fashion (maximally depressing to 16
.2 + 1.9% baseline developed force for TNF-alpha and 25.7 + 6.3% baseline d
eveloped force for IL-1 beta), affecting systolic relatively more than dias
tolic performance teach p < .05). However, when combined, TNF-alpha and IL-
1 beta at concentrations that did not individually result in depression (p
>.05 vs, control) resulted in contractile depression (p < .05 vs. control).
Inhibition of myocardial sphingosine or NO release abolished the myocardia
l depressive effects of either TNF-alpha or IL-1 beta.
Conclusions:TNF-alpha and IL-1 beta separately and synergistically depress
human myocardial function. Sphingosine likely participates in the TNF-alpha
and IL-1 beta signal leading to human myocardial functional depression. Th
erapeutic strategies to reduce production or signaling of either TNF-alpha
or IL-1 beta may limit myocardial dysfunction in sepsis.